In addition previous studies in advanced NSCLC patients had showed that changes in CEA or CYFRA21-1 levels during chemotherapy [8, 38], radiochemotherapy [39] or targeted therapy [15, 16], had a higher predictive value than baseline level alone, indicating the usefulness of both markers for treatment monitoring. Here, CEACAM5 is linked to non-small cell lung carcinoma.